iMetabolic Biopharma Corporation — Form C-AR (Regulation Crowdfunding)
iMetabolic Biopharma Corporation of Tempe, AZ filed a Form C-AR (Regulation Crowdfunding) with the SEC on 2023-04-27.
Offering
- Filed: 2023-04-27
- Form: C-AR
- Accession: 0001665160-23-000924
Issuer
- CIK: 0001957114
- Website: https://imbiopharma.com/
- Legal status: Corporation
- Organized in: NV
- Incorporated: 2017-11-17
- Address: 2155 E Conference Dr STE 115, Tempe, AZ, 85284-2604
- Employees: 4
Financials (as filed)
- Total assets (most recent): $5K
- Cash (most recent): $5K
- Net income (most recent): $-95K
- Net income (prior): $-64K
- Long-term debt: $161K
People (4)
| Name | Role | Location |
|---|
| Urban Austin Kiernan | Chairman, President, Treasurer and Principle Financial Officer | TEMPE, AZ |
| Jeffrey D. Zimmerman | Secretary and General Counsel | TEMPE, AZ |
| Urban A. Kiernan | CEO | TEMPE, AZ |
| Urban A Kiernan | CEO | TEMPE, AZ |
Reg CF filing history (8)
More